Literature DB >> 15225137

Unabated anorexic and enhanced thermogenic responses to melanotan II in diet-induced obese rats despite reduced melanocortin 3 and 4 receptor expression.

G Li1, Y Zhang, J T Wilsey, P J Scarpace.   

Abstract

The effects of the chronic activation of the central melanocortin (MC) system by melanotan II (MTII) were assessed in chow-fed (CH) and high-fat (HF) diet-induced obese (DIO) Sprague-Dawley rats. Six-day central infusion of MTII (1 nmol/day) reduced body weight and visceral adiposity compared with ad libitum-fed control and pair-fed groups and markedly suppressed caloric intake in both CH and DIO rats. The anorexic response to MTII was similar in DIO relative to CH rats. MTII induced a sustained increase in oxygen consumption in DIO but a delayed response in CH rats. In both diet groups, MTII reduced serum insulin and cholesterol levels compared with controls. HF feeding increased brown adipose tissue (BAT) uncoupling protein 1 (UCP1) by over twofold, and UCP1 levels were further elevated in MTII-treated CH and DIO rats. MTII lowered acetyl-CoA carboxylase expression and prevented the reduction in muscle-type carnitine palmitoyltransferase I mRNA by pair-feeding in the muscle of DIO rats. Compared with CH controls, hypothalamic MC3 and MC4 receptor expression levels were reduced in DIO controls. This study has demonstrated that, despite reduced hypothalamic MC3/MC4 receptor expression, anorexic and thermogenic responses to MTII are unabated with an initial augmentation of energy expenditure in DIO versus CH rats. The HF-induced up-regulation of UCP1 in BAT may contribute to the immediate increase in MTII-stimulated thermogenesis in DIO rats. MTII also increased fat catabolism in the muscle of DIO rats and improved glucose and cholesterol metabolism in both groups.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225137     DOI: 10.1677/joe.0.1820123

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  15 in total

1.  Pro-opiomelanocortin gene transfer to the nucleus of the solitary track but not arcuate nucleus ameliorates chronic diet-induced obesity.

Authors:  Y Zhang; E Rodrigues; Y X Gao; M King; K Y Cheng; B Erdös; N Tümer; C Carter; P J Scarpace
Journal:  Neuroscience       Date:  2010-06-09       Impact factor: 3.590

2.  Simultaneous POMC gene transfer to hypothalamus and brainstem increases physical activity, lipolysis and reduces adult-onset obesity.

Authors:  Yi Zhang; Enda Rodrigues; Gang Li; Yongxin Gao; Michael King; Christy S Carter; Nihal Tumer; Kit-Yan Cheng; Philip J Scarpace
Journal:  Eur J Neurosci       Date:  2011-03-02       Impact factor: 3.386

3.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

4.  Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction.

Authors:  I Côté; Y Sakarya; N Kirichenko; D Morgan; C S Carter; N Tümer; P J Scarpace
Journal:  Can J Physiol Pharmacol       Date:  2016-10-19       Impact factor: 2.273

5.  Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.

Authors:  Jocelyn M Bischof; Lex H T Van Der Ploeg; William F Colmers; Rachel Wevrick
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

6.  Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness.

Authors:  G Li; Y Zhang; K Y Cheng; P J Scarpace
Journal:  Diabetologia       Date:  2007-05-16       Impact factor: 10.122

7.  Intermittent MTII application evokes repeated anorexia and robust fat and weight loss.

Authors:  Yi Zhang; Renata Collazo; Yongxin Gao; Gang Li; Philip J Scarpace
Journal:  Peptides       Date:  2009-12-23       Impact factor: 3.750

8.  The central melanocortin system directly controls peripheral lipid metabolism.

Authors:  Ruben Nogueiras; Petra Wiedmer; Diego Perez-Tilve; Christelle Veyrat-Durebex; Julia M Keogh; Gregory M Sutton; Paul T Pfluger; Tamara R Castaneda; Susanne Neschen; Susanna M Hofmann; Philip N Howles; Donald A Morgan; Stephen C Benoit; Ildiko Szanto; Brigitte Schrott; Annette Schürmann; Hans-Georg Joost; Craig Hammond; David Y Hui; Stephen C Woods; Kamal Rahmouni; Andrew A Butler; I Sadaf Farooqi; Stephen O'Rahilly; Françoise Rohner-Jeanrenaud; Matthias H Tschöp
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice.

Authors:  Y C Loraine Tung; Sarah J Piper; Debra Yeung; Stephen O'Rahilly; Anthony P Coll
Journal:  Endocrinology       Date:  2006-09-07       Impact factor: 4.736

10.  Reduced anorexigenic efficacy of leptin, but not of the melanocortin receptor agonist melanotan-II, predicts diet-induced obesity in rats.

Authors:  Gertjan van Dijk; Koert de Vries; Csaba Nyakas; Bauke Buwalda; Tiziana Adage; Folkert Kuipers; Martien J H Kas; Roger A H Adan; Charles W Wilkinson; Todd E Thiele; Anton J W Scheurink
Journal:  Endocrinology       Date:  2005-09-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.